Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Seagen Inc. | d481013dex322.htm |
| EX-32.1 - EX-32.1 - Seagen Inc. | d481013dex321.htm |
| EX-31.2 - EX-31.2 - Seagen Inc. | d481013dex312.htm |
| EX-31.1 - EX-31.1 - Seagen Inc. | d481013dex311.htm |
| EX-21.1 - EX-21.1 - Seagen Inc. | d481013dex211.htm |
| EX-10.56 - EX-10.56 - Seagen Inc. | d481013dex1056.htm |
| EX-10.35 - EX-10.35 - Seagen Inc. | d481013dex1035.htm |
| EX-10.29 - EX-10.29 - Seagen Inc. | d481013dex1029.htm |
| EX-10.18 - EX-10.18 - Seagen Inc. | d481013dex1018.htm |
| EX-10.17 - EX-10.17 - Seagen Inc. | d481013dex1017.htm |
| 10-K - FORM 10-K - Seagen Inc. | d481013d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-212688, 333-204331, 333-197992, 333-188446, 333-176144, 333-168672, 333-148188, 333-56670) of Seattle Genetics, Inc., and the Registration Statement on Form S-3 (No. 333-206846) of our report dated February 21, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which is incorporated in this Annual Report on Form 10-K.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
February 21, 2017